Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Acquires Synthetic Nucleic Acid Manufacturer SynPro

NEW YORK, April 17 (GenomeWeb News) - Agilent Technologies said today that it has acquired SynPro, a privately held manufacturer of synthetic nucleic acids based in Boulder, Colo.


Financial details of the agreement were not disclosed.


SynPro manufactures short synthetic DNA and RNA molecules. Agilent estimated that the size of the RNA and DNA synthesis market is currently around $700 million, with anticipated growth in the range of 10 to 20 percent per year.


SynPro will join Agilent's New Business Group. Agilent has hired 22 employees from the firm.